Lisa Graver
Net worth: 106 667 $ as of 2026-05-30
Net worth: 106 667 $ as of 2026-05-30
Lisa Graver is currently Chief Executive Officer at Norwich Pharmaceuticals, Inc., Chief Executive Officer at Alvotech (title starting 2026), Director at Alvotech hf, and President at Almaject, Inc. Former positions include Chief Executive Officer at Alvogen, Inc. from 2010 to 2025, Chief Executive Officer at Alvogen Pharma US, Inc., Senior Director & VP-Intellectual Property at Actavis, Inc. from 2006 to 2008, and Associate at Kirkland & Ellis LLP.
Education includes undergraduate studies at the University of Lakehead and graduate studies at Case Western Reserve University School of Law.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALVOTECH 0.01% | 2026-03-05 | 31,746 ( 0.01% ) | 106 667 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ALVOTECH | Chief Executive Officer | 2026-02-28 |
Almaject, Inc.
Almaject, Inc. Pharmaceuticals: GenericHealth Technology Engages in development, acquisition and commercialization of injectable generic pharmaceutical products | President | - |
Norwich Pharmaceuticals, Inc.
Norwich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides contract manufacturing and clinical services for the pharmaceuticals industry | Chief Executive Officer | - |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Chief Executive Officer | 2025-11-30 |
Alvogen Pharma US, Inc.
Alvogen Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Chief Executive Officer | 2025-11-30 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Corporate Officer/Principal | 2007-12-31 |
Kirkland & Ellis LLP
Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Kirkland & Ellis LLP
Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
University of Lakehead
University of Lakehead Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norwich Pharmaceuticals, Inc.
Norwich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides contract manufacturing and clinical services for the pharmaceuticals industry | Health Technology |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Alvogen Pharma US, Inc.
Alvogen Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Case Western Reserve University School of Law
Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Almaject, Inc.
Almaject, Inc. Pharmaceuticals: GenericHealth Technology Engages in development, acquisition and commercialization of injectable generic pharmaceutical products | Health Technology |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions